No adverse events were observed in clozapine-treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan.
Hata M, Fujimoto M, Kanai K, Yoshiyama K, Nakatani Y, Nakabayashi D, Maemura S, Kawata S, Hakozaki T, Nishikura S, Umemoto A, Sasada T, Iwata K, Tanaka H, Mamoto A, Toi Y, Taniguchi N, Saito M, Kimura Y, Kishimoto K, Hayami M, Ikeda M.
Hata M, et al. Among authors: nakatani y.
Neuropsychopharmacol Rep. 2021 Jun;41(2):179-184. doi: 10.1002/npr2.12166. Epub 2021 Feb 19.
Neuropsychopharmacol Rep. 2021.
PMID: 33606356
Free PMC article.